The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
Open accessAbstract
Summary The RV144 HIV-1 trial of the canary pox vector (ALVAC-HIV) plus the gp120 AIDSVAX B/E vaccine demonstrated an estimated efficacy of 31%, that correlated directly with antibodies to HIV-1 envelope variable regions 1 and 2 (V1–V2). Genetic analysis of trial viruses revealed increased vaccine efficacy against viruses matching the vaccine strain at V2 residue 169. Here, we isolated four V2 monoclonal antibodies from RV144 vaccinees that recognize residue 169, neutralize laboratory-adapted HIV-1, and mediate killing of field isolate HIV-1-infected CD4+ T cells. Crystal structures of two of the V2 antibodies demonstrated residue 169 can exist within divergent helical and loop conformations, which contrasted dramatically with the beta strand conformation previously observed with a broadly neutralizing antibody PG9. Thus, RV144 vaccine-induced immune pressure appears to target a region that may be both sequence variable and structurally polymorphic. Variation may signal sites of HIV-1 envelope vulnerability, providing vaccine designers with new options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
Self-citationKeele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,912
Self-citationLeaver-Fay (2011) · doi:10.1016/b978-0-12-381270-4.00019-6 · Cited by 1,904
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Haynes, B. F., Gilbert, P. B., McElrath, M. J., Zolla-Pazner, S., Tomaras, G. D., Alam, S. M., Evans, D. T., Montefiori, D. C., Karnasuta, C., Sutthent, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113425 · Cited by 1,808
Self-citationBroad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7
Langer, G., Cohen, S. X., Lamzin, V. S., & Perrakis, A. (2008) · Nature Protocols · doi:10.1038/nprot.2008.91 · Cited by 1,606
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
McLellan, J. S., Pancera, M., Carrico, C., Gorman, J., Julien, J.-P., Khayat, R., Louder, R., Pejchal, R., Sastry, M., Dai, K., et al. (2011) · Nature · doi:10.1038/nature10696 · Cited by 830
Self-citationSeaman, M. S., Janes, H., Hawkins, N., Grandpre, L. E., Devoy, C., Giri, A., Coffey, R. T., Harris, L., Wood, B., Daniels, M. G., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02108-09 · Cited by 632
Self-citationEvaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays
Montefiori, D. C. (2004) · Current Protocols in Immunology · doi:10.1002/0471142735.im1211s64 · Cited by 580
Self-citationArthos, J., Cicala, C., Martinelli, E., Macleod, K., Van Ryk, D., Wei, D., Xiao, Z., Veenstra, T. D., Conrad, T. P., Lempicki, R. A., et al. (2008) · Nature Immunology · doi:10.1038/ni1566 · Cited by 580
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
Haynes, B. F., Kelsoe, G., Harrison, S. C., & Kepler, T. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2197 · Cited by 486
Self-citationBonsignori, M., Hwang, K.-K., Chen, X., Tsao, C.-Y., Morris, L., Gray, E., Marshall, D. J., Crump, J. A., Kapiga, S. H., Sam, N. E., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05045-11 · Cited by 423
Self-citationIncreased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
Rolland, M., Edlefsen, P. T., Larsen, B. B., Tovanabutra, S., Sanders-Buell, E., Hertz, T., deCamp, A. C., Carrico, C., Menis, S., Magaret, C. A., et al. (2012) · Nature · doi:10.1038/nature11519 · Cited by 417
Self-citationBonsignori, M., Pollara, J., Moody, M. A., Alpert, M. D., Chen, X., Hwang, K.-K., Gilbert, P. B., Huang, Y., Gurley, T. C., Kozink, D. M., et al. (2012) · Journal of Virology · doi:10.1128/jvi.01023-12 · Cited by 375
Self-citationNomenclature for Immune Correlates of Protection After Vaccination
Plotkin, S. A., & Gilbert, P. B. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis238 · Cited by 347
The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
Karlsson Hedestam, G. B., Fouchier, R. A. M., Phogat, S., Burton, D. R., Sodroski, J., & Wyatt, R. T. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1819 · Cited by 339
Montefiori, D. C., Karnasuta, C., Huang, Y., Ahmed, H., Gilbert, P., de Souza, M. S., McLinden, R., Tovanabutra, S., Laurence-Chenine, A., Sanders-Buell, E., et al. (2012) · Journal of Infectious Diseases · doi:10.1093/infdis/jis367 · Cited by 284
Self-citationAlam, S. M., McAdams, M., Boren, D., Rak, M., Scearce, R. M., Gao, F., Camacho, Z. T., Gewirth, D., Kelsoe, G., Chen, P., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4424 · Cited by 260
Self-citationLiao, H.-X., Levesque, M. C., Nagel, A., Dixon, A., Zhang, R., Walter, E., Parks, R., Whitesides, J., Marshall, D. J., Hwang, K.-K., et al. (2009) · Journal of Virological Methods · doi:10.1016/j.jviromet.2009.02.014 · Cited by 255
Self-citationFerrari, G., Pollara, J., Kozink, D., Harms, T., Drinker, M., Freel, S., Moody, M. A., Alam, S. M., Tomaras, G. D., Ochsenbauer, C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00171-11 · Cited by 233
Self-citationGenetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial
Rolland, M., Tovanabutra, S., deCamp, A. C., Frahm, N., Gilbert, P. B., Sanders-Buell, E., Heath, L., Magaret, C. A., Bose, M., Bradfield, A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2316 · Cited by 225
Self-citationPancera, M., McLellan, J. S., Wu, X., Zhu, J., Changela, A., Schmidt, S. D., Yang, Y., Zhou, T., Phogat, S., Mascola, J. R., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00966-10 · Cited by 224
Self-citationKarasavvas, N., Billings, E., Rao, M., Williams, C., Zolla-Pazner, S., Bailer, R. T., Koup, R. A., Madnote, S., Arworn, D., Shen, X., et al. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0103 · Cited by 211
Self-citationLiao, H.-X., Chen, X., Munshaw, S., Zhang, R., Marshall, D. J., Vandergrift, N., Whitesides, J. F., Lu, X., Yu, J.-S., Hwang, K.-K., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110363 · Cited by 204
Self-citationHigh‐throughput quantitative analysis of HIV‐1 and SIV‐specific ADCC‐mediating antibody responses
Pollara, J., Hart, L., Brewer, F., Pickeral, J., Packard, B. Z., Hoxie, J. A., Komoriya, A., Ochsenbauer, C., Kappes, J. C., Roederer, M., et al. (2011) · Cytometry Part A · doi:10.1002/cyto.a.21084 · Cited by 202
Self-citationEdmonds, T. G., Ding, H., Yuan, X., Wei, Q., Smith, K. S., Conway, J. A., Wieczorek, L., Brown, B., Polonis, V., West, J. T., et al. (2010) · Virology · doi:10.1016/j.virol.2010.08.028 · Cited by 192
Self-citationLiao, H.-X., Sutherland, L. L., Xia, S.-M., Brock, M. E., Scearce, R. M., Vanleeuwen, S., Alam, S. M., McAdams, M., Weaver, E. A., Camacho, Z. T., et al. (2006) · Virology · doi:10.1016/j.virol.2006.04.043 · Cited by 184
Self-citationTrkola, A., Matthews, J., Gordon, C., Ketas, T., & Moore, J. P. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.8966-8974.1999 · Cited by 180
Structure–function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design
Zolla‐Pazner, S., & Cardozo, T. J. (2010) · Nature reviews. Immunology · doi:10.1038/nri2801 · Cited by 163
Self-citationNawaz, F., Cicala, C., Ryk, D. V., Block, K. E., Jelicic, K., McNally, J. P., Ogundare, O., Pascuccio, M., Patel, N., Wei, D., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001301 · Cited by 144
Alam, S. M., Scearce, R. M., Parks, R., Plonk, K., Plonk, S. G., Sutherland, L. L., Górny, M. K., Zolla‐Pazner, S., Vanleeuwen, S., Moody, M. A., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00927-07 · Cited by 120
Self-citationAlam, S. M., Liao, H., Tomaras, G. D., Bonsignori, M., Tsao, C.-Y., Hwang, K., Chen, H., Lloyd, K. E., Bowman, C. M., Sutherland, L. L., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00718-12 · Cited by 97
Self-citationMa, B.-J., Alam, S. M., Go, E. P., Lu, X., Desaire, H., Tomaras, G. D., Bowman, C. M., Sutherland, L. L., Scearce, R. M., Santra, S., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002200 · Cited by 85
Self-citationGórny, M. K., Pan, R., Williams, C. A. U., Wang, X., Volsky, B., O'Neal, T., Spurrier, B., Sampson, J. M., Li, L., Seaman, M. S., et al. (2012) · Virology · doi:10.1016/j.virol.2012.02.003 · Cited by 83
Self-citationDoria‐Rose, N. A., Georgiev, I. S., O'Dell, S. J., Chuang, G., Staupe, R. P., McLellan, J. S., Gorman, J., Pancera, M., Bonsignori, M., Haynes, B. F., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00696-12 · Cited by 82
Self-citationHIV-1 gp120 Vaccine Induces Affinity Maturation in both New and Persistent Antibody Clonal Lineages
Moody, M. A., Yates, N. L., Amos, J. D., Drinker, M. S., Eudailey, J., Gurley, T. C., Marshall, D. J., Whitesides, J. F., Chen, X., Foulger, A., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00426-12 · Cited by 77
Self-citationBonsignori, M., Moody, M. A., Parks, R., Holl, T. M., Kelsoe, G. H., Hicks, C. B., Vandergrift, N., Tomaras, G. D., & Haynes, B. F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901068 · Cited by 76
Self-citationLeaman, D. P., Kinkead, H. L., & Zwick, M. B. (2010) · Journal of Virology · doi:10.1128/jvi.02363-09 · Cited by 50
Burrer, R., Haessig-Einius, S., Aubertin, A.-M., et al. (2005) · Virology · doi:10.1016/j.virol.2004.12.034 · Cited by 38
Cited by
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Liao, H.-X., Lynch, R., Zhou, T., Gao, F., Alam, S. M., Boyd, S. D., Fire, A. Z., Roskin, K. M., Schramm, C. A., Zhang, Z., et al. (2013) · Nature · doi:10.1038/nature12053 · Cited by 988
Self-citationEfficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
Hammer, S. M., Sobieszczyk, M. E., Janes, H., Karuna, S. T., Mulligan, M. J., Grove, D., Koblin, B. A., Buchbinder, S. P., Keefer, M. C., Tomaras, G. D., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310566 · Cited by 598
Self-citationHIV‐1 neutralizing antibodies: understanding nature's pathways
Mascola, J. R., & Haynes, B. F. (2013) · Immunological Reviews · doi:10.1111/imr.12075 · Cited by 475
Self-citationYates, N. L., Liao, H.-X., Fong, Y., deCamp, A., Vandergrift, N. A., Williams, W. T., Alam, S. M., Ferrari, G., Yang, Z.-Y., Seaton, K. E., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007730 · Cited by 450
Self-citationAntibody responses to envelope glycoproteins in HIV-1 infection
Burton, D. R., & Mascola, J. R. (2015) · Nature Immunology · doi:10.1038/ni.3158 · Cited by 385
Self-citation
Metadata
- Authors
- Liao, H.-X., Bonsignori, M., Alam, S. M., McLellan, J. S., Tomaras, G. D., Moody, M. A., Kozink, D. M., Hwang, K.-K., Chen, X., Tsao, C.-Y., Liu, P., Lu, X., Parks, R. J., Montefiori, D. C., Ferrari, G., Pollara, J., Rao, M., Peachman, K. K., Santra, S., Letvin, N. L., Karasavvas, N., Yang, Z.-Y., Dai, K., Pancera, M., Gorman, J., Wiehe, K., Nicely, N. I., Rerks-Ngarm, S., Nitayaphan, S., Kaewkungwal, J., Pitisuttithum, P., Tartaglia, J., Sinangil, F., Kim, J. H., Michael, N. L., Kepler, T. B., Kwong, P. D., Mascola, J. R., Nabel, G. J., Pinter, A., Zolla-Pazner, S., & Haynes, B. F.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 38
- Issue
- 1
- Pages
- 176-186
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W1985145726
- Cited by
- 377
- References
- 42
- FWCI
- 24.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.